PONATINIB HCL

Ponatinib HCl is a tyrosine kinase inhibitor targeting BCR‑ABL and resistant T315I mutations, used in chronic myeloid leukemia. Benefits include effective control of resistant disease. Side effects include hypertension, arterial thrombosis, pancreatitis, rash, myelosuppression, and hepatotoxicity.

SKU: 6e41f3d03e78 Category: Tag:

Product Description


Scientific Overview

PONATINIB HCL (ID 27186) is a research‑grade biochemical compound used for advanced analytical, mechanistic and structural studies. It is often applied in laboratory environments requiring precise molecular behaviour, controlled pathway modulation and high‑fidelity reproducibility. The compound interacts with multiple biochemical systems depending on formulation, cell type and experimental conditions.

Mechanism of Action

Although the exact mechanism may vary by experimental model, PONATINIB HCL typically exhibits activity involving:

  • Enzymatic pathway modulation through reversible or irreversible interaction with catalytic sites
  • Potential receptor‑level signaling effects influencing intracellular second messengers
  • Alterations in redox balance and oxidative‑stress handling systems
  • Mitochondrial functional modulation, including effects on ATP turnover and respiratory‑chain efficiency
  • Influence on transcriptional behaviour, gene‑expression clusters and regulatory protein networks
  • Possible interaction with cytoskeletal structures affecting cellular stability and mechanical signaling

These combined effects make the compound suitable for multi‑axis biochemical research.

Benefits and Applications

PONATINIB HCL is commonly used for:

  • Pathway validation and mechanistic investigation
  • Binding‑affinity studies and structural modelling
  • Metabolic‑flux analysis and mitochondrial‑function profiling
  • Redox and oxidative‑stress research environments
  • Cytoskeletal and membrane‑dynamic studies
  • Signal‑transduction mapping across diverse biological systems

Risks and Safety Considerations

Potential risks associated with laboratory exposure include:

  • Oxidative imbalance or ROS accumulation
  • Mitochondrial stress or functional suppression at high concentrations
  • Unintended receptor or enzyme cross‑interaction
  • Cytoskeletal destabilization or membrane disturbance
  • Dose‑dependent cytotoxicity under prolonged exposure

Handle only with appropriate laboratory biosafety protocols.

Datasheet


Molecular Formula

C29H27ClF3N5O·HCl

Molecular Weight

569.0 g/mol

CAS Number

1114544-31-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Ponatinib hydrochloride; 1114544-31-8; Iclusig; AP 24534 hydrochloride; AP24534 HCL

IUPAC/Chemical Name

3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide;hydrochloride

InChl Key

BWTNNZPNKQIADY-UHFFFAOYSA-N

InChl Code

InChI=1S/C29H27F3N6O.ClH/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37;/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39);1H

References

https://pubchem.ncbi.nlm.nih.gov/compound/46908927;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download